Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
MD

MD - MEDNAX Inc Stock Price, Fair Value and News

$20.66+0.13 (+0.63%)
Market Closed

52/100

MD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

52/100

MD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$22.04

Target 3M

$21.67

Target 6M

$21.8

MD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MD Price Action

Last 7 days

-6.4%

Last 30 days

-5.6%

Last 90 days

18.8%

Trailing 12 Months

42.9%

MD RSI Chart

MD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MD Valuation

Market Cap

1.8B

Price/Earnings (Trailing)

10.94

Price/Sales (Trailing)

0.92

EV/EBITDA

8.85

Price/Free Cashflow

6.12

MD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$22.04

Target 3M

$21.67

Target 6M

$21.8

MD Fundamentals

MD Revenue

Revenue (TTM)

1.9B

Rev. Growth (Yr)

-3.58%

Rev. Growth (Qtr)

5.13%

MD Earnings

Earnings (TTM)

162.2M

Earnings Growth (Yr)

268.85%

Earnings Growth (Qtr)

82.65%

MD Profitability

EBT Margin

10.62%

Return on Equity

18.21%

Return on Assets

7.37%

Free Cashflow Yield

16.35%

MD Investor Care

Buy Backs (1Y)

0.00%

Diluted EPS (TTM)

1.91

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.0B1.9B1.9B0
20242.0B2.0B2.0B2.0B
20232.0B2.0B2.0B2.0B
20221.9B2.0B2.0B2.0B
20211.7B1.8B1.8B1.9B
20201.8B1.8B1.8B1.7B
20193.0B2.6B2.2B1.8B
20183.5B3.5B3.5B3.5B
20173.3B3.3B3.4B3.5B
20162.9B3.0B3.1B3.2B
20152.5B2.6B2.7B2.8B
20142.2B2.3B2.4B2.4B
20131.9B2.0B2.1B2.2B
20121.6B1.7B1.8B1.8B
20111.5B1.5B1.6B1.6B
20100001.4B
Get all data in R, Python etc through our Historical Stock Data APIs

About MEDNAX Inc

MD
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
 CEO
 WEBSITEpediatrix.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES5250

MEDNAX Inc Frequently Asked Questions

MD is the stock ticker symbol of MEDNAX Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of MEDNAX Inc is 1.77 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check MD's fair value in chart for subscribers.

The fair value guage provides a quick view whether MD is over valued or under valued. Whether MEDNAX Inc is cheap or expensive depends on the assumptions which impact MEDNAX Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MD.

As of Wed Jan 28 2026, MD's PE ratio (Price to Earnings) is 10.94 and Price to Sales (PS) ratio is 0.92. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, MEDNAX Inc has provided -0.114 (multiply by 100 for percentage) rate of return.